Holding company
Jilin Huikang Biopharmaceutical Co., Ltd. is located at No. 3088 Changji South Line, Erdao District, Changchun City. With Kong Wei as its legal representative, the company is a high-tech enterprise approved by the Jilin Provincial Administration for Market Regulation and Drug Administration, dedicated to the research, development, and production of biological vaccines. The company occupies approximately 50,000 square meters and is equipped with a biologics manufacturing workshop, a central laboratory, and an animal facility.
Since its establishment in October 2001, Wellcome has been dedicated to the research and application of large-scale, high-density cell culture technologies. In August 2007, Wellcome’s production facility for human rabies vaccine (Vero cell–based) obtained GMP certification and was issued a certificate (Certificate No.: I4299).
Human rabies vaccine (Vero cell–derived) is a preventive biological product that, upon administration, stimulates the body to produce immunity against the rabies virus. Our company’s Vero cell–derived rabies vaccine is manufactured using a microcarrier-based Vero cell culture process to produce the viral seed stock, followed by bioreactor cultivation. This integrated approach combines suspension culture and adherent culture, thereby leveraging the advantages of both methods. It simplifies the monitoring and control of various environmental factors in cell production, ensures excellent reproducibility and stability of the culture system, significantly increases viral titers, and results in a high vaccine potency, reaching internationally advanced standards.
Public Information in Accordance with the Vaccine Administration Law
Supervision and Management:
GMP Compliance: Our company strictly adheres to national laws and regulations and has established a comprehensive set of standardized operating procedures covering procurement, manufacturing, quality control, cold-storage warehousing, cold-chain transportation, and after-sales service, thereby ensuring product quality.
Recall Status: None at the moment
Undergo inspection: Information is being updated.
Penalty details: Since its establishment, our company has never received any penalties.
Mandatory vaccine insurance: Updating
Vaccine Batch Release: See the "Batch Release" section on the website's homepage